Deletion of the G protein-coupled Receptor GPR30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-stimulated Insulin Release in Female Mice.
(2009) In Endocrinology 150(2). p.687-698- Abstract
- In vitro studies suggest that the G protein-coupled receptor GPR30 is a functional estrogen receptor. However, the physiological role of GPR30 in vivo is unknown, and it remains to be determined if GPR30 is an estrogen receptor also in vivo. To this end, we studied the effects of disrupting the GPR30 gene in female and male mice. Female GPR30((-/-)) mice had hyperglycemia and impaired glucose tolerance, reduced body growth, increased blood pressure, and reduced serum insulin-like growth factor-I levels. The reduced growth correlated with a proportional decrease in skeletal development. The elevated blood pressure was associated with an increased vascular resistance manifested as an increased media:lumen ratio of the resistance arteries.... (More)
- In vitro studies suggest that the G protein-coupled receptor GPR30 is a functional estrogen receptor. However, the physiological role of GPR30 in vivo is unknown, and it remains to be determined if GPR30 is an estrogen receptor also in vivo. To this end, we studied the effects of disrupting the GPR30 gene in female and male mice. Female GPR30((-/-)) mice had hyperglycemia and impaired glucose tolerance, reduced body growth, increased blood pressure, and reduced serum insulin-like growth factor-I levels. The reduced growth correlated with a proportional decrease in skeletal development. The elevated blood pressure was associated with an increased vascular resistance manifested as an increased media:lumen ratio of the resistance arteries. The hyperglycemia and impaired glucose tolerance in vivo were associated with decreased insulin expression and release in vivo and in vitro in isolated pancreatic islets. GPR30 is expressed in islets, and GPR30 deletion abolished estradiol-stimulated insulin release both in vivo in ovariectomized adult mice and in vitro in isolated islets. Our findings show that GPR30 is important for several metabolic functions in female mice including estradiol-stimulated insulin release. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1262362
- author
- organization
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Endocrinology
- volume
- 150
- issue
- 2
- pages
- 687 - 698
- publisher
- Oxford University Press
- external identifiers
-
- wos:000262851200016
- pmid:18845638
- scopus:59649122739
- ISSN
- 0013-7227
- DOI
- 10.1210/en.2008-0623
- language
- English
- LU publication?
- yes
- id
- 88635a63-05ce-43c5-ab63-0279f9a28757 (old id 1262362)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18845638?dopt=Abstract
- date added to LUP
- 2016-04-01 11:37:54
- date last changed
- 2022-04-28 17:44:13
@article{88635a63-05ce-43c5-ab63-0279f9a28757, abstract = {{In vitro studies suggest that the G protein-coupled receptor GPR30 is a functional estrogen receptor. However, the physiological role of GPR30 in vivo is unknown, and it remains to be determined if GPR30 is an estrogen receptor also in vivo. To this end, we studied the effects of disrupting the GPR30 gene in female and male mice. Female GPR30((-/-)) mice had hyperglycemia and impaired glucose tolerance, reduced body growth, increased blood pressure, and reduced serum insulin-like growth factor-I levels. The reduced growth correlated with a proportional decrease in skeletal development. The elevated blood pressure was associated with an increased vascular resistance manifested as an increased media:lumen ratio of the resistance arteries. The hyperglycemia and impaired glucose tolerance in vivo were associated with decreased insulin expression and release in vivo and in vitro in isolated pancreatic islets. GPR30 is expressed in islets, and GPR30 deletion abolished estradiol-stimulated insulin release both in vivo in ovariectomized adult mice and in vitro in isolated islets. Our findings show that GPR30 is important for several metabolic functions in female mice including estradiol-stimulated insulin release.}}, author = {{Mårtensson, Ulrika and Salehi, S Albert and Windahl, Sara and Gomez, Maria and Swärd, Karl and Daszkiewicz-Nilsson, Joanna and Wendt, Anna and Andersson, Niklas and Hellstrand, Per and Grände, Per-Olof and Owman, Christer and Rosen, Clifford J and Adamo, Martin L and Lundquist, Ingmar and Rorsman, Patrik and Nilsson, Bengt-Olof and Ohlsson, Claes and Olde, Björn and Leeb-Lundberg, Fredrik}}, issn = {{0013-7227}}, language = {{eng}}, number = {{2}}, pages = {{687--698}}, publisher = {{Oxford University Press}}, series = {{Endocrinology}}, title = {{Deletion of the G protein-coupled Receptor GPR30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-stimulated Insulin Release in Female Mice.}}, url = {{http://dx.doi.org/10.1210/en.2008-0623}}, doi = {{10.1210/en.2008-0623}}, volume = {{150}}, year = {{2009}}, }